z-logo
open-access-imgOpen Access
Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts
Author(s) -
Natalie Palavra,
Sharon L. Naismith,
Simon J.G. Lewis
Publication year - 2013
Publication title -
neurology research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.365
H-Index - 31
eISSN - 2090-1852
pISSN - 2090-1860
DOI - 10.1155/2013/576091
Subject(s) - medicine , dementia , parkinson's disease , cognitive impairment , disease , cognition , cognitive decline , psychological intervention , intensive care medicine , psychiatry , pathology
Mild Cognitive Impairment in Parkinson's Disease (PD-MCI) is common and may be associated with accelerated progression to dementia. Considering the importance of this emerging entity, new diagnostic criteria have recently been proposed. Early recognition and accurate classification of PD-MCI could offer opportunities for novel therapeutic interventions. This review discusses current definitions for PD-MCI, the screening tools used, the pattern of cognitive deficits observed, and the predictors of cognitive decline and transition to Parkinson's Disease Dementia. Emerging biomarkers, which may aid diagnosis, are also explored and the role of novel treatment options is considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom